Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37
United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Lew
2 Mar 2026
EVP & Chief Financial Officer
Sell
5,565
$5.42
$30.16K
Dean Richard Artis
2 Mar 2026
EVP & Chief Scientific Officer
Sell
5,894
$5.43
$32.00K
Ted Yednock
2 Mar 2026
EVP & Chief Innovation Officer
Sell
5,566
$5.42
$30.17K
Michael Overdorf
2 Mar 2026
EVP & Chief Business Officer
Sell
4,339
$5.42
$23.52K
Jamie Dananberg
2 Mar 2026
Chief Medical Officer
Sell
5,820
$5.43
$31.60K
Michael Overdorf
18 Feb 2026
EVP & Chief Business Officer
Sell
6,225
$5.10
$31.75K
Ted Yednock
18 Feb 2026
EVP & Chief Innovation Officer
Sell
7,857
$5.11
$40.15K
Dean Richard Artis
18 Feb 2026
EVP & Chief Scientific Officer
Sell
5,290
$5.10
$26.98K
Jennifer Lew
18 Feb 2026
EVP & Chief Financial Officer
Sell
7,851
$5.11
$40.12K
Jamie Dananberg
18 Feb 2026
Chief Medical Officer
Sell
5,290
$5.10
$26.98K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 336,896
History held since 24 Jul 2020